BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 25187721)

  • 1. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications.
    Chou TY; Hong BY
    Ther Clin Risk Manag; 2014; 10():665-81. PubMed ID: 25187721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ganciclovir in the treatment of acute herpetic keratitis.
    Tabbara KF; Al Balushi N
    Clin Ophthalmol; 2010 Aug; 4():905-12. PubMed ID: 20823931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
    Kaufman HE; Haw WH
    Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?
    Sahin A; Hamrah P
    Ophthalmol Eye Dis; 2012; 4():23-34. PubMed ID: 23650455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
    Colin J
    Clin Ophthalmol; 2007 Dec; 1(4):441-53. PubMed ID: 19668521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers).
    Croxtall JD
    Drugs; 2011 Mar; 71(5):603-10. PubMed ID: 21443283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Cochrane Database Syst Rev; 2010 Dec; (12):CD002898. PubMed ID: 21154352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
    Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
    Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy.
    Castela N; Vermerie N; Chast F; Sauvageon-Martre H; Denis J; Godard V; Goldschmidt P; Pouliquen Y
    J Ocul Pharmacol; 1994; 10(2):439-51. PubMed ID: 8083563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
    Carter SB; Cohen EJ
    Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic interventions for herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Cochrane Database Syst Rev; 2008 Jan; (1):CD002898. PubMed ID: 18254009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of herpes simplex virus epithelial keratitis.
    Roozbahani M; Hammersmith KM
    Curr Opin Ophthalmol; 2018 Jul; 29(4):360-364. PubMed ID: 29697435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group.
    Wilhelmus KR; Dawson CR; Barron BA; Bacchetti P; Gee L; Jones DB; Kaufman HE; Sugar J; Hyndiuk RA; Laibson PR; Stulting RD; Asbell PA
    Br J Ophthalmol; 1996 Nov; 80(11):969-72. PubMed ID: 8976723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic interventions for herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002898. PubMed ID: 17253484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The latest in herpes simplex keratitis therapy].
    Labetoulle M
    J Fr Ophtalmol; 2004 May; 27(5):547-57. PubMed ID: 15179314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis.
    Wang X; Wang L; Wu N; Ma X; Xu J
    Chin Med J (Engl); 2015 Jan; 128(1):46-50. PubMed ID: 25563312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Cochrane Database Syst Rev; 2003; (3):CD002898. PubMed ID: 12917935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
    Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.